Partners

France

Université de Paris (UP)

The Université de Paris is a multidisciplinary university devoted to Health and Humanity sciences research and one of the most important research poles in France. It attracts 39,000 students including 1,500 PhD students gathered in 9 Research and Training Departments and more than 1,300 researchers and 2,000 lecturer-researchers gathered in 73 research teams that often work in close connection with the Institut National de la Recherche Médicale (INSERM) and/or the Centre National de la Recherche Scientifique (CNRS).

Research covers a very wide range in the field of humanities and social sciences, psychology, law and economics, biology, medicine, dentistry and pharmacy. Chemistry, mathematics and computer sciences are also represented and placed at the interface with biomedical sciences, thus bringing the necessary fundamental input to assess and modelling human activities. The spectrum of human phenomena addressed by research at Paris University is broad spanning reproductive and early development of the embryo up until the build-up of the human psyche and its connections with familal and social environments, including the rules and conventions governing collective life and individual rights.

In 2010, the Université de Paris was ranked by the Higher Education Evaluation and Accreditation Council of Taiwan as the first French University reputed by its excellence in medical research.

The Office of European grants provides assistance to researchers in obtaining and managing sponsored awards that support research and scholarly activities. More than twenty European projects are managed by the Office of European grants, including FP7 and H2020 projects. The Université de Paris is involved in projects of all types (European Research Council, Marie Skłodowska-Curie actions, and collaborative projects) both as partner and coordinator.

 

The Université de Paris actively promotes gender balance. It has set a « Mission pour la parité hommes/femmes à l’Université » which involves students, faculty and administrative staff, for promoting an educational environment based on egalitarian opportunities and treatment for men and women.

Role in project

UP is the Clinical Coordinator for the EURAMED rocc-n-roll project (WP1: Tasks 1.1 and 1.3), ensuring that the project will have a significant clinical relevance in term of integration with the health sector, and also to transfer the main results into practical recommendations to the EC. UP also contributes to WP3 – The health perspective and risk benefit approach (Tasks 3.1-3.5), WP4 – Infrastructures, digitisation and digitalisation: approaches and ethics (Task 4.1), WP5 – Industrial research, innovation and sustainability (Tasks 5.1 and 5.2), WP6 – SRA, roadmap and the interlink document (Tasks 6.1-6.3), and WP7 – Education and Training in medical application of ionising radiation and related radiation protection (Tasks 7.1 and 7.2).

Institut de Radioprotection et de Sûreté Nucléaire (IRSN)

The Institut de radioprotection et de sûreté nucléaire (IRSN) is a public organization placed under the joint authority of the French Ministries of the Environment, Health, Research, Industry and Defense. Serving public authorities, IRSN is a body performing research and providing expert assessments into nuclear and radiological risks. It covers the radiological protection of humans, the protection of the environment, the emergency response to radiological and nuclear events, the safety of nuclear reactors, the safety of plants, laboratories, radioactive material transport and waste, the prevention of major accidents in nuclear power plants, as well as the nuclear defence expertise.

IRSN has a strong experience in low-dose and high-dose risk research:

  • In term of low-dose risk research, IRSN has launched two major national programs aiming to (i) identify biological disorders in a wide range of experimental models after long-term exposures to low-doses of ionising radiation; (ii) evaluate to what extent non-cancer effects, such as cardiac rhythm disorders and lens opacities, are observed in children living in the Russian territories contaminated with Cs-137.
  • In term of high-dose risk research, IRSN has developed research programs aiming to (i) better understand the mechanisms giving rise to secondary effects in radiotherapy assess and treat these side effects; (ii) manage patients accidentally overexposed to ionising radiation.

To support the abovementioned research activities, IRSN has implemented transversal activities in dosimetry (external, internal, biological) and epidemiology (follow-up of cohorts of people exposed to environmental, mining, nuclear, and medical exposures).

IRSN has a previous experience in EC-funded projects. Among others, IRSN has led Work Package 2, “Structuring MELODI”, and Work Package 7, “Non-cancer effects” of the DoReMi network of excellence. Furthermore, IRSN coordinated the OPERRA project, and leads several tasks within the CONCERT project.

IRSN is one of the founding members of the MELODI Association and a member of the EURAMED, ALLIANCE, NERIS and EURADOS platforms. IRSN is partner of the MEDIRAD project.

 

IRSN has extensive expertise in dosimetry, radiobiology, radiopathology, biostatistics, and epidemiology, as well as experience in supporting the administrative and financial aspects of international projects. IRSN has established strong national and international collaborations with universities, nuclear operators, research laboratories and hospitals.

Role in project

IRSN leads Task 2.1 Concepts from MELODI (identifying relevant parts of their SRA) and Task 6.3 The interlinks inside European radiation research and into the other programmes. In addition, IRSN contributes to Task 2.6 Evaluation of regulators’ needs and expectations, Tasks 3.1 Radiation protection in oncology, Task 4.1 Infrastructures for medical radiation protection research, and Tasks 6.1 and 6.2 on the SRA and roadmap.

Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA)

The French Alternative Energies and Atomic Energy Commission (CEA) is a government-funded technological research organization dedicated to connecting the worlds of research and industry.

The CEA is active, on the one hand, in four major fields: energy, defense & global security, information technologies and health technologies, associated with fundamental research of excellence, and on the other, in the design and operation of very large research infrastructures. Through fundamental research in biology, physics and chemistry, the basic research division (DRF) strongly contributes to all of CEA research programs in many fields of expertise, from renewable and nuclear energy, to health, lasers, micro and nanotechnology. DRF participate in the development of technological facilities/platforms, very large research infrastructures, high performance computing, and also take part in theoretical physics investigation at the highest level internationally. In this framework, the partnership policy of DRF aims to ensure better research coordination, networking of skills and optimization of resources, at national and international level. DRF currently hosts 1900 persons involved in Biology and Health studies. The life sciences have been present at the CEA ever since its inception and its aims have always been dual: 1) to apply technology generated by nuclear science to healthcare and biotechnology, for understanding the structure and operation of complex living systems in vitro and in vivo 2) to understand and assess the effects of nuclear energy use on health and the environment, especially at low exposure levels, for making a scientifically sound assessment of the radiological and chemical risks arising from nuclear energy use in both the short and long terms. The CEA implements an extremely proactive policy on working with its European partners, being involved in more than hundreds of projects in FP7-H2020, notably through technological platforms and the implementation of new forms of partnership between research institutes and industry in certain targeted sectors.

 

The CEA’s Technological Research division (DRT) draws together applied research activities in the following key fields for industrial innovation: micro and nanotechnologies, software-intensive systems, new technologies for energy and nanomaterials. CEA/ DRT-LIST is a key software, systems and technology unit, with more than 700 researchers and engineers working for societal and economic implications.

Role in project

CEA leads Task 4.1 Infrastructures for medical radiation protection research, which includes defining the need, the possibility, the risks and the criteria in establishing a center of excellence. It also contributes to WP2 (Task 2.1 Identification and prioritisation of MELODI SRA topics relevant to medical radiation protection research) as well as to other tasks according to the expertise needed.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Get a Quote